CAROL ANN TAMMINGA, MD
Psychiatric at Harry Hines Blvd, Dallas, TX
License number
Texas 40443
Category
Psychiatric
Type
Psychiatry
Address
Address
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 648-5555
Personal information
See more information about CAROL ANN TAMMINGA at radaris.comName
Address
Phone
5720 Forest Park Rd, Dallas, TX 75235
Dallas, TX
5510 Nakoma Dr, Dallas, TX 75209
5720 Forest Park Rd, Dallas, TX 75235
Professional information
Professor And Interim Chair At Ut Southwestern Medical Center
Position:
Professor and Interim Chair at UT Southwestern Medical Center
Location:
Dallas/Fort Worth Area
Industry:
Research
Work:
UT Southwestern Medical Center
-
Professor and Interim Chair
Dr. Carol A Tamminga, Dallas TX - MD (Doctor of Medicine)
Specialties:
Clinical Pharmacology, Psychiatry
Address:
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-2961 (Fax)
2201 Inwood Rd, Dallas 75235
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-9050 (Fax)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-2961 (Fax)
2201 Inwood Rd, Dallas 75235
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 648-9050 (Fax)
Dallas
5323 Harry Hines Blvd, Dallas 75390
(214) 648-3111 (Phone), (214) 645-0078 (Fax)
Languages:
English
Education:
Medical School
Vanderbilt University
Graduated: 1971
Vanderbilt University
Graduated: 1971
Carol Ann Tamminga, Dallas TX
Specialties:
Clinical Pharmacology, Neurology, Psychiatry
Work:
Southwestern Medical Center
2201 Inwood Rd, Dallas, TX 75235 Psychiatry Dept
6363 Forest Park Rd, Dallas, TX 75235
2201 Inwood Rd, Dallas, TX 75235 Psychiatry Dept
6363 Forest Park Rd, Dallas, TX 75235
Education:
Vanderbilt University (1971)
Use Of Dopamine Stabilizers
US Patent:
2010019, Aug 5, 2010
Filed:
Jun 18, 2008
Appl. No.:
12/452145
Inventors:
Arvid Carlsson - Gothenburg, SE
Carol A. Tamminga - Dallas TX, US
Maria L. Carlsson - Gothenburg, SE
Johan Rung - Askim, SE
Marie Nilsson - Hisings Backa, SE
Adrienne C. Lahti - Birmingham AL, US
Carol A. Tamminga - Dallas TX, US
Maria L. Carlsson - Gothenburg, SE
Johan Rung - Askim, SE
Marie Nilsson - Hisings Backa, SE
Adrienne C. Lahti - Birmingham AL, US
International Classification:
A61K 31/4418, A61P 25/10, A61P 1/08, A61P 25/16, A61P 25/18, A61P 25/14, A61P 25/30, A61P 25/22
US Classification:
514277
Abstract:
At least one embodiment of the present invention relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 1-20 mg or in an intravenous daily dose of 0.1-2 mg in treatment of a neurological or psychiatric disorder characterized by a hypofunction of the dopamine system. At least one embodiment of the invention also relates to the use of a dopamine stabilizing substance in an oral, subcutaneous or intramuscular daily dose of 25-50 mg in treatment of a disorder caused by instability of neural circuits.
Methods For Diagnosing And Treating Schizophrenia
US Patent:
2007001, Jan 18, 2007
Filed:
Dec 11, 2003
Appl. No.:
10/538339
Inventors:
Francis Buxton - Winchester MA, US
William Carpenter - Columbia MD, US
Rosalinda Roberts - Columbia MD, US
Carol Tamminga - Dallas TX, US
William Carpenter - Columbia MD, US
Rosalinda Roberts - Columbia MD, US
Carol Tamminga - Dallas TX, US
Assignee:
Novartis AG - Basel
University of Maryland - Baltimore MD
University of Maryland - Baltimore MD
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The genes encoding SCYA2, GADD45B, S100A8, CDKN1A, IL1RL1, TGM2, MAFF, SERPINA3, GRO1, CD14, KIAA1075, CHI3L1, SERPINH1, MT1X, KIAA0620, TIMP1, NUMA1, DDIT3 and TOB2, are upregulated in the anterior cingulate of schizophrenic patients compared to normal patients and as such are useful drug targets for schizophrenia. Methods of screening, diagnosing and treating schizophrenia based on these genes are provided. Transgenic nonhuman animals having increased copy number or increased expression levels of these genes are also provided. The transgenic nonhuman animals are used in methods for screening for potential therapeutic agents.
Method For Diagnosing And Treating Schizophrenia
US Patent:
2005022, Oct 13, 2005
Filed:
Mar 19, 2003
Appl. No.:
10/507858
Inventors:
Francis Buxton - Winchester MA, US
William Carpenter - Columbia MD, US
Rosalinda Roberts - Columbia MD, US
Carol Tamminga - Dallas TX, US
William Carpenter - Columbia MD, US
Rosalinda Roberts - Columbia MD, US
Carol Tamminga - Dallas TX, US
International Classification:
C12Q001/68, A61K048/00
US Classification:
435006000, 514044000
Abstract:
The gene encoding decidual protein induced by progesterone (DEPP), the gene encoding adrenomedullin and the gene encoding cold shock domain protein A (csdA), are upregulated in the anterior cingulate of schizophrenic patients as compared to normal patients. Methods of screening, diagnosing and treating schizophrenia based on these genes are provided. Transgenic nonhuman animals having increased copy number or increased expression levels of these genes are also provided. The transgenic nonhuman animals are used in methods of screening for potential therapeutic agents.